Ru Jiang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ru Jiang

Showing results (251-260 of 254) with videos related to

Pageof 26

Sort By:

You have reached the last page of results.This site can display upto 254 results.

Journal of Integrative Medicine|February 16, 2021

Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trialJie Wu, Shu-Wei Duan, Hong-Tao Yang, et al.

Science Translational Medicine|September 11, 2024

BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AMLBijender Kumar, Anand Singh, Rafet Basar, et al.

Blood|September 9, 2020

Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cellsMay Daher, Rafet Basar, Elif Gokdemir, et al.

Nature|June 4, 2025

CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cellsHind Rafei, Rafet Basar, Sunil Acharya, et al.

Pageof 26

Search research articles

Showing results (251-260 of 254) with videos related to

Sort By:

Pageof 26

You have reached the last page of results.This site can display upto 254 results.

Journal of Integrative Medicine|February 16, 2021

Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trialJie Wu, Shu-Wei Duan, Hong-Tao Yang, et al.

Science Translational Medicine|September 11, 2024

BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AMLBijender Kumar, Anand Singh, Rafet Basar, et al.

Blood|September 9, 2020

Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cellsMay Daher, Rafet Basar, Elif Gokdemir, et al.

Nature|June 4, 2025

CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cellsHind Rafei, Rafet Basar, Sunil Acharya, et al.

Pageof 26